Aurinia Pharmaceuticals Inc (AUPH)
5.025
-0.15
(-2.85%)
USD |
NASDAQ |
May 10, 16:00
5.025
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Price to Book Value: 1.901 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.957 |
| May 08, 2024 | 1.949 |
| May 07, 2024 | 1.937 |
| May 06, 2024 | 1.953 |
| May 03, 2024 | 1.930 |
| May 02, 2024 | 1.956 |
| May 01, 2024 | 1.968 |
| April 30, 2024 | 1.921 |
| April 29, 2024 | 1.896 |
| April 26, 2024 | 1.858 |
| April 25, 2024 | 1.852 |
| April 24, 2024 | 1.912 |
| April 23, 2024 | 1.935 |
| April 22, 2024 | 1.920 |
| April 19, 2024 | 1.897 |
| April 18, 2024 | 1.829 |
| April 17, 2024 | 1.867 |
| April 16, 2024 | 1.901 |
| April 15, 2024 | 1.916 |
| April 12, 2024 | 1.939 |
| April 11, 2024 | 1.931 |
| April 10, 2024 | 1.897 |
| April 09, 2024 | 1.943 |
| April 08, 2024 | 1.893 |
| April 05, 2024 | 1.920 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.935 |
| April 03, 2024 | 1.969 |
| April 02, 2024 | 1.931 |
| April 01, 2024 | 2.053 |
| March 28, 2024 | 1.917 |
| March 27, 2024 | 1.913 |
| March 26, 2024 | 1.886 |
| March 25, 2024 | 1.909 |
| March 22, 2024 | 1.902 |
| March 21, 2024 | 1.917 |
| March 20, 2024 | 1.967 |
| March 19, 2024 | 1.982 |
| March 18, 2024 | 1.948 |
| March 15, 2024 | 1.978 |
| March 14, 2024 | 1.948 |
| March 13, 2024 | 2.009 |
| March 12, 2024 | 1.990 |
| March 11, 2024 | 2.055 |
| March 08, 2024 | 2.078 |
| March 07, 2024 | 2.085 |
| March 06, 2024 | 2.112 |
| March 05, 2024 | 2.143 |
| March 04, 2024 | 2.204 |
| March 01, 2024 | 2.212 |
| February 29, 2024 | 2.189 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.379
Minimum
Dec 27 2022
18.88
Maximum
Dec 26 2019
4.749
Average
4.157
Median
May 15 2019
Price to Book Value Benchmarks
| Lexaria Bioscience Corp | 7.055 |
| Acasti Pharma Inc | 0.4011 |
| Edesa Biotech Inc | 2.469 |
| Xenon Pharmaceuticals Inc | 3.299 |
| ESSA Pharma Inc | 1.931 |
Price to Book Value Related Metrics
| PS Ratio | 4.094 |
| Price | 5.025 |
| Earnings Yield | -10.55% |
| Market Cap | 718.67M |